Open access
ADC – ANTIBODY-DRUG CONJUGATES IN ONCOLOGY
Jędrzej Kowalski
Dominik Szymczak
Olaf Zołotar
Marcin Szczepanik
Natalia Pociej
Jakub Senko
Joanna Kulpa
Zofia Suchanek
Wojciech Pociej
Krzysztof Dzierbunowicz
Sep 2026 · International Journal of Innovative Technologies in Social Science · 0 citations
· 34 references
Abstract
Background: Antibody-drug conjugates (ADC) are a promising novel therapy for oncology patients as it combines tumor- targeted antibodies with cytotoxic molecules resulting in improved therapeutic outcomes. Aim: The aim of this article is a thorough analysis of ADC possibilities in oncology focusing on treatment options, side effects of therapies for breast, bladder and lung cancers. Material and methods: A search of relevant research databases was conducted to identify eligible papers. Results: Findings reveal ADC to be a promising treatment option as a innovative, more precise form of therapy.